Search for: "Ema" Results 121 - 140 of 524
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
27 May 2019, 7:22 am by Michael Connell
At issue in this reference case was a proposed amendment to BC’s Environmental Management Act (“EMA”) dealing with “hazardous substance permits” that would give BC permitting authority over the Trans Mountain pipeline. [read post]
26 Apr 2019, 1:47 am
In some cases, they have also created ema... [read post]
22 Apr 2019, 5:15 pm by Howard Bashman
” And Ema O’Connor of BuzzFeed News reports that “The Supreme Court Will Decide Whether Employers Can Discriminate Against LGBT Employees; The court will look at whether Title VII of the Civil Rights Act, which prevents discrimination ‘on the basis of sex,’ applies to LGBT individuals. [read post]
16 Apr 2019, 2:12 pm by Tom Lamb
Points Out New Reports Of Conditions Beyond Those That Were Covered In November 2018 FDA Drug Safety Communication   (Posted by Tom Lamb at DrugInjuryWatch.com)   We recently learned by means of this April 12, 2019 European Medicines Agency (EMA) press release, "Use of multiple sclerosis medicine Lemtrada restricted while EMA review is ongoing", that the multiple sclerosis (MS) drug Lemtrada (alemtuzumab) is facing more scrutiny from drug regulators. [read post]
10 Apr 2019, 6:50 pm by Howard Bashman
In related news from elsewhere, Ema O’Connor of BuzzFeed News reports that “Ohio Has Once Again Passed A Bill To Ban Abortion After A Month And A Half; This Time The Governor Says He’ll Sign It. [read post]
20 Mar 2019, 5:22 am by Kluwer Patent blogger
(…) we must not make the same mistakes as happened with the assignment of the EMA. [read post]
21 Feb 2019, 3:47 am by Katherine A. Campbell
It remains to be seen whether the EMA will apply to the European Court of Justice for a declaration under European law on the EMA’s power to sublet, or whether it will seek leave to appeal to a higher court. [read post]
7 Feb 2019, 5:18 am by Kluwer Patent blogger
So it’s important that EMA- and FDA-approved Lutathera is also available to patients. [read post]
6 Feb 2019, 6:12 am
Regulation of medicinal productsGuestKat Frantzeska Papadopoulou explored the issue of the regulation of orphan drugs in the context of the General Court decision on an action brought by Bristol-Myers Squibb Pharma (BMS) against the Commission and the European Medicines Agency (EMA) in the case T‑329/16: Orphan Drugs, a successful regulation after all? [read post]
24 Jan 2019, 11:05 pm by Lawrence B. Ebert
These recommendations have recently been re-evaluated by EMA's Committee for Medicinal Products for Human Use (CHMP), and confirmed the final opinion of the European Medicines Agency. [read post]
14 Jan 2019, 9:58 am by Howard Bashman
“Trump’s New Birth Control Rules Are Going Into Effect In A Majority Of States Following A Judge’s Limited Ruling”: Ema O’Connor of BuzzFeed News has this report. [read post]
4 Jan 2019, 9:16 pm
On  December 5, 2018, the General Court ruled in favor of the European Commission in an action brought by Bristol-Myers Squibb Pharma (BMS) against the Commission and the European Medicines Agency (EMA) in the case, T‑329/16, read here. [read post]
11 Dec 2018, 4:29 pm by Jeffrey P. Gale, P.A.
The E/C objected to the medical opinions in the depositions based on section 440.13(5)(e), Florida Statutes (2014), which prohibits the admission of medical opinion evidence in workers’ compensation proceedings from anyone other than an authorized treating physician, independent medical examiner (IME), or expert medical advisor (EMA). [read post]
4 Dec 2018, 1:44 am by Kluwer Patent blogger
According to the Dutch daily Het Parool, 850 EMA staff members will move as well and the number of EMA employees will eventually be 1300. [read post]
19 Nov 2018, 1:44 pm by Tom Lamb
By comparison, the European Medicines Agency (EMA) informed about a potential increased risk of lower limb amputations (mostly affecting the toes) in patients taking the any of the SGLT2 inhibitors, including Farxiga and Jardiance as well as Invokana,  in February 2017. [read post]
17 Nov 2018, 1:54 am by Alan Johnson
  It would appear that if this Protocol remains in place in the longer term (post- the expiration of the Transition Period), MAs granted by the EMA will continue to apply to Northern Ireland whereas the UK will have its own separate national regime (unless the UK is permitted to continue as a part of the EMA). [read post]
16 Nov 2018, 4:00 am by Alan Johnson
  It would appear that if this Protocol remains in place in the longer term (post- the expiration of the Transition Period), MAs granted by the EMA will continue to apply to Northern Ireland whereas the UK will have its own separate national regime (unless the UK is permitted to continue as a part of the EMA). [read post]
14 Sep 2018, 10:30 am by Ronald V. Miller, Jr.
According to the European Medicines Agency (EMA), NDEA has been found in valsartan made by ZHP since they changed its manufacturing process in 2012. [read post]
3 Sep 2018, 6:28 pm by Carolyn E. Pepper and Demelza Hassani
The UK pharmaceuticals sector is a key industry seeking clarity, particularly on the following important areas: Continued membership of the UK in the European Medicines Agency (EMA) regime. [read post]